The current status of anti-GPCR drugs against different cancers
G protein coupled receptors (GPCRs) have emerged as the most potential target for a number of drug discovery programs ranging from control of blood pressure, diabetes, cure for genetic diseases to treatment of cancer. A panel of different ligands including hormones, peptides, ions and small molecule...
Saved in:
Main Authors: | Sana Usman (Author), Maria Khawer (Author), Shazia Rafique (Author), Zara Naz (Author), Komal Saleem (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening of GPCR drugs for repurposing in breast cancer
by: Noor Mazin Abdulkareem, et al.
Published: (2022) -
GPCR Conformations: Implications for Rational Drug Design
by: Abby L. Parrill, et al.
Published: (2010) -
Disrupting GPCR Complexes with Smart Drug-like Peptides
by: Maria Gallo, et al.
Published: (2022) -
Expanding the Concept of G Protein-Coupled Receptor (GPCR) Dimer Asymmetry towards GPCR-Interacting Proteins
by: Ralf Jockers, et al.
Published: (2011) -
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies
by: Martin J. Scott, et al.
Published: (2020)